2.92
-0.19(-6.11%)
Currency In USD
Previous Close | 3.11 |
Open | 3.06 |
Day High | 3.13 |
Day Low | 2.85 |
52-Week High | 3.49 |
52-Week Low | 0.76 |
Volume | 48,221 |
Average Volume | 101,135 |
Market Cap | 110.43M |
PE | -6.64 |
EPS | -0.44 |
Moving Average 50 Days | 2.28 |
Moving Average 200 Days | 1.72 |
Change | -0.19 |
If you invested $1000 in Apyx Medical Corporation (APYX) since IPO date, it would be worth $451.31 as of October 19, 2025 at a share price of $2.92. Whereas If you bought $1000 worth of Apyx Medical Corporation (APYX) shares 5 years ago, it would be worth $507.83 as of October 19, 2025 at a share price of $2.92.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Apyx Medical Corporation Submits FDA 510(k) for Device Label Expansion of AYON Body Contouring System™ for Power Liposuction
GlobeNewswire Inc.
Oct 13, 2025 12:00 PM GMT
Initiated Nationwide Commercial Launch of AYON in September The Company is Hosting a Virtual Key Opinion Leader Event to Discuss the Commercial Launch of AYON on October 14, 2025 CLEARWATER, Fla., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corp
Apyx Medical to Host Virtual Key Opinion Leader Event to Discuss the Commercial Launch of The AYON Body Contouring System™ on October 14, 2025
GlobeNewswire Inc.
Sep 29, 2025 12:00 PM GMT
CLEARWATER, Fla., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion® and the AYON B
Apyx Medical Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire Inc.
Aug 07, 2025 8:06 PM GMT
CLEARWATER, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical”; the “Company”) today announced that on August 4, 2025, Apyx granted a nonstatuatory stock option to purchase 100,000 shares of common stock